Behavioral, Developmental Disorders in Children More Common in Recent Years

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 26, 2025.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Feb. 26, 2025 -- The prevalence of children's behavioral and developmental disorders increased nationally from 2019 to 2022, with some conditions linked to caregivers' mental well-being, according to a study recently published in Pediatric Reports.

Austin Lent, from Florida Atlantic University in Boca Raton, and colleagues examined the nationwide prevalence of childhood behavioral, mental, and developmental problems in U.S. youth (aged 6 to 11 years). The analysis included data from the National Survey of Children’s Health (2019 to 2022).

The researchers observed increases across many conditions, including anxiety (9.5 percent in 2020 to 11 percent in 2022), behavioral and conduct problems (9.2 percent in 2019 to 10.3 percent in 2022), and autism spectrum disorder (3 percent in 2019 to 4.25 percent in 2022). Attention-deficit disorder (ADD) and attention-deficit/hyperactivity disorder (ADHD) peaked at 12.8 percent in 2022. Caregivers with "fair" mental health had roughly 2.5 times higher odds of having a child with severe behavioral or conduct issues in 2019, while caregivers with "poor" mental health in 2020 had roughly 3.7 times higher odds of having a child with severe behavioral or conduct issues. Caregiver mental and emotional health were also associated with childhood ADD and ADHD prevalence rates, with caregivers with "poor" mental health having roughly 4.6 times higher odds of having a child with severe ADD/ADHD as caregivers who reported "excellent" mental and emotional health.

"While we did not find any significant links between caregiver mental health and childhood autism or depression, our findings support the need for a holistic approach to addressing childhood mental, behavioral, and developmental disorders, one that includes caregiver well-being as a key factor," senior author Lea Sacca, Ph.D., also from Florida Atlantic University, said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-02-27 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords